Montelukast Prescribing at CORE CARE FAMILY PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
483
Total Quantity
11.6K
NHS Cost
£560
vs National Avg
-29.5%
CORE CARE FAMILY PRACTICE prescribed 483 items of Montelukast over the last 12 months at a cost of £560 to the NHS. This is 29.5% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
51
Jun 2026
41
Jun 2026
45
Jun 2026
41
Jun 2026
35
Jun 2026
39
Jun 2026
39
Jun 2026
39
Jun 2026
39
Jun 2026
35
Jun 2026
41
Jun 2026
38
Prescribing Details
| Total Items | 483 |
|---|---|
| Total Quantity | 11,627 |
| Total NHS Cost | £560 |
| Presentations | 3 different forms |
| vs National Average | -29.5% |
Montelukast Prescribing Comparison
| This practice | 483 items |
|---|---|
| National average per practice | 685 items |
| Difference | -29.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.